SUBSCRIBE
SUBSCRIBE
News   Business

Ipsen’s First Quarter 2007 Sales

May 3, 2007 | 
1 min read
+7.0% Growth in Group Sales, +9.4% Growth in Volume Sold Strong Dynamics in Strategic Targeted Therapeutic Areas: +12.8% Solid Growth Outside the Five Major Western European Countries: +20.7%
Earnings Europe
Ipsen Biopharmaceuticals, Inc.
MORE ON THIS TOPIC
Human liver organ and pills. World hepatitis day. National liver health awareness month. Liver transplantation, donation background. Save patient life in hospital with liver transplant
Postmarket research
Amgen’s rare disease drug Tavneos tied to 20 deaths in Japan
May 18, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Takeda cuts 4,500, Novartis lays off biomedical research staff
May 15, 2026
 · 
54 min read
 · 
BioSpace Editorial Staff
Sorting garbage concept. Cropped photo of paper thash. Crumple paper falling to the recycling bin
Drug Development
Genmab drops 2 antibody assets, including another ProfoundBio ADC
May 15, 2026
 · 
2 min read
 · 
Gabrielle Masson
Vector illustration. Product recall.
Manufacturing
Sun Pharma recalls cancer drug after finding glass particles in some vials
May 15, 2026
 · 
2 min read
 · 
Nick Paul Taylor